In Other News

• New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

• New Blood Test Aims to Transform Liver Cancer Surveillance

• Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype

• Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU

• AI-Powered Blood Test Distinguishes Deadly Cardiac Events

• Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype

• Blood Immune 'Fingerprint' Predicts Side Effects of New Alzheimer's Drug

• New Chromogenic Culture Media Enable Rapid Detection of Candida Infections

• Clinical Diagnostic Test Detects Additional Genetic Variants in Acute Leukemia Patients

• AI-Powered Blood Test Distinguishes Deadly Cardiac Events

• MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

• Blood Test Predicts Dementia in Women 25 Years Before Symptoms Begin

• Serial Liquid Biopsies Reveal Therapy Resistance in Metastatic Prostate Cancer

• Rapid RSV Tests Reduces Antibiotic Prescribing in Kids

• DNA Aptamers Offer New Tool for Easy Alzheimer's Blood Test

• Jumping "DNA Parasites” Linked to Early Tumor Development

• AI-Based Liquid Biopsy Detects Liver Fibrosis, Cirrhosis and Chronic Disease Signals

• Blood Test Could Detect Pre-Eclampsia Before Symptoms Appear

• Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits

• Blood Test Tracks Transplant Health Using Donor DNA

• AI-Based Liquid Biopsy Detects Liver Fibrosis, Cirrhosis and Chronic Disease Signals

• Blood Test Tracks Transplant Health Using Donor DNA

• Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical